NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
11.83
+0.13 (1.11%)
At close: Aug 26, 2025, 4:00 PM
11.90
+0.07 (0.59%)
After-hours: Aug 26, 2025, 7:48 PM EDT
NovoCure Market Cap
NovoCure has a market cap or net worth of $1.32 billion as of August 26, 2025. Its market cap has decreased by -36.64% in one year.
Market Cap
1.32B
Enterprise Value
1.11B
1-Year Change
-36.64%
Ranking
Category
Stock Price
$11.83
Market Cap Chart
Since October 2, 2015, NovoCure's market cap has decreased from $1.51B to $1.32B, a decrease of -12.49%. That is a compound annual growth rate of -1.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 1.31B | -59.43% |
| Dec 31, 2024 | 3.22B | 102.11% |
| Dec 29, 2023 | 1.60B | -79.28% |
| Dec 30, 2022 | 7.70B | -1.24% |
| Dec 31, 2021 | 7.79B | -55.75% |
| Dec 31, 2020 | 17.62B | 111.21% |
| Dec 31, 2019 | 8.34B | 167.82% |
| Dec 31, 2018 | 3.11B | 72.52% |
| Dec 29, 2017 | 1.81B | 164.99% |
| Dec 30, 2016 | 681.20M | -63.57% |
| Dec 31, 2015 | 1.87B | 23.71% |
| Oct 2, 2015 | 1.51B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |